SANJIVANI PARANTERAL LTD.

Sanjivani Paranteral Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in place until 48 hours after the Un-audited Financial Results for the First Quarter Ended June 30, 2026, are made public. The company has informed all officers and designated employees, including directors and auditors, about this restriction to prevent any trading during this period. This measure is standard practice before the announcement of financial results.

Ashwani Khemka, identified as belonging to the Promoter group, has acquired an additional 16,875 shares, representing 0.14% of the total share capital, in Sanjivani Paranteral Limited through open market transactions. This acquisition brings his total shareholding to 36,70,117 shares, or 29.88% of the company's total voting capital. The transaction occurred on June 24, 2026, with the company's equity share capital remaining unchanged at ₹12,28,43,000/- (1,22,84,300 shares at ₹10/- each) both before and after the acquisition.

Ashwani Khemka, a promoter of Sanjivani Paranteral Limited, has acquired 17,500 shares, representing 0.14% of the total share capital, through open market transactions. This acquisition increases his total shareholding to 36,53,242 shares, or 29.74% of the company's total share capital. The transaction was disclosed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total equity share capital of the company remains unchanged at Rs. 12,28,43,000/-.

Sanjivani Paranteral Ltd's board approved the appointment of Mr. Bhavesh M. Rathod, a Chartered Accountant Registered Valuer, to carry out the valuation and determination of the issue price for proposed warrants. These warrants will be issued via preferential issue, subject to member and regulatory approvals, including BSE Limited. The decision was made at a board meeting held on May 21, 2026, which commenced at 11:30 A.M. and concluded at 01:00 P.M.

Sanjivani Paranteral Ltd (BSE: 531569) reported its audited financial results for FY26. The company's total income stood at ₹697.56 mn, with EBITDA at ₹114.00 mn and PAT at ₹66.94 mn. The EBITDA margin was 16.34%, and the PAT margin was 9.60%. The company's injectables segment contributed 53.45% to revenue, while tablets grew by approximately 7.5% YoY. Exports contributed 78.50% of revenue. Commercial production commenced at the new IV Fluid Infusion Plant in Pune.

Sanjivani Paranteral Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve a proposal for raising funds. The fundraising may involve issuing equity shares, warrants, or other instruments through preferential issue, private placements, qualified institutional placements, or other suitable methods, subject to regulatory and shareholder approvals.

Sanjivani Paranteral Ltd. announced the approval of audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, during its board meeting held on May 14, 2026. The meeting, which commenced at 04:00 P.M. and concluded at 05:30 P.M., included a review of the audit report. R. B. Gohil & Co., Chartered Accountants, conducted the audit and issued an independent auditor's report, stating that the financial results present a true and fair view in accordance with regulatory requirements and accounting standards.

Sanjivani Paranteral Ltd. announced the approval of audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026, during its board meeting held on May 14, 2026. The audit report, conducted by R. B. Gohil & Co., Chartered Accountants, expresses an unqualified opinion on the financial results, stating they present a true and fair view in accordance with applicable accounting standards and Listing Regulations.

Sanjivani Paranteral Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited standalone and consolidated financial results along with the audit report for the fourth quarter and financial year ended March 31, 2026. The trading window, currently closed, will remain closed until 48 hours after the announcement of the audited financial results.

Sanjivani Paranteral Ltd has released its annual disclosure under Regulation 31(4) of SEBI (SAST) 2011. The disclosure was received from the Promoter of the Company on behalf of the Promoter and Promoter Group for the Financial Year ended 31st March, 2026. The company confirmed that the members of Promoter and Promoter Group including Persons acting in Concert did not make any encumbrance, directly or indirectly, over the shares of the Company during the Financial Year Ended 31st March, 2026.